Augmentation of fibroblast proliferation by bleomycin.
AUTOR(ES)
Moseley, P L
RESUMO
Bleomycin-induced lung disease is characterized by fibroblast proliferation and pulmonary fibrosis. In these studies, we demonstrate that fibroblasts are relatively resistant to clinically relevant amounts (below 10(-4) U/ml) of bleomycin and that these levels of bleomycin augment fibroblast proliferation in response to various fibroblast growth factors. These observations suggest that one mechanism by which bleomycin causes pulmonary fibrosis is augmentation of fibroblast proliferation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=423797Documentos Relacionados
- Elimination of multicopy plasmid R6K by bleomycin.
- DNA structure influences sequence specific cleavage by bleomycin.
- Growth phase dependency of chromatin cleavage and degradation by bleomycin.
- Cells containing factor XIIIa and pulmonary fibrosis induced by bleomycin.
- The response of ataxia telangiectasia cells to bleomycin.